Morgan Stanley Reiterates Equalweight Rating on Oracle

Analyst: Sanjit Singh 1 min read Reproduced verbatim
Rating
Equalweight
Unchanged
Target
$207
Unchanged
Outcome
Reached
on May 29, 2026
Morgan Stanley and Oracle logos

What the analyst said

Morgan Stanley analyst Sanjit Singh reiterated an Equalweight rating and $207.00 price target on Oracle (NYSE: ORCL).

“On the back of a solid Q3, with shares moving 30%+ higher intra-quarter, a more mixed print to cap off FY26 underwhelmed relative to expectations – driving a negative reaction after hours.

While Cloud Infrastructure Revenues of ~$5.8B accelerated to 93% YoY growth, incremental deceleration in Cloud Applications drove total Cloud revenue towards the midpoint of the guided range at +46% YoY on a constant-currency basis, and just ~50bps of upside to consensus on total revenue.

More constructively, NGAAP gross margins of 66.3% improved sequentially (though still down 500bps YoY), while NGAAP operating margins of 44.8% upticked both sequentially and YoY (on account of intra-quarter efficiency actions) – driving a ~7% beat to consensus EPS.

Additionally, RPO of $638B increased $85B sequentially, and was up 363% YoY – with the majority of the increase tied to pre-payment / bring your own hardware deal structures.

Looking to FY27, Q2 Cloud revenue guidance came in 3% ahead of consensus (contemplating 61% YoY growth at the midpoint), while EPS came in 3.6% ahead of consensus (at the midpoint).

That said, FY27 total revenue guidance was reiterated at $90 billion, and FY27 EPS guidance of $8.05 remains largely unchanged relative to the $8.00 target provided during the October 2025 Analyst Day.

From here, as Oracle enters and advances through the peak of its GPUaaS investment cycle, investors remain focused on near-term execution before underwriting the ambitious multi-year targets the company is aspiring to.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $207 target is 11% below the median.

Since the note ORCL has moved −43% (from $201). 12-month window: day 147 of 365, closes on June 11, 2027.

Track record

This call✓ Target reached on May 29, 2026, 36 days after the note. Same target as this firm’s April 23, 2026 note, so it is scored there.

Firm track recordMorgan Stanley: 82% of its 49 targets at least a year old were reached within 12 months (#8 of 26 firms). Accuracy ranking →

Earnings reactionOne of 18 notes after Oracle’s Jun 10 results: 6 raised · 2 cut · 10 kept. See every call →

Morgan Stanley on Oracle

Morgan Stanley price targets on Oracle

4 calls from January 23, 2026 to September 4, 2026. The target went from $213 to $210 (−1%). The rating stayed Hold.

Morgan Stanley targetORCL share price
  1. September 4, 2026Target raised from $207 (+1%)Hold$210
  2. June 11, 2026 This noteKept the $207 targetHold$207
  3. April 23, 2026Target cut from $213 (−3%)$207
  4. January 23, 2026Earliest call shown$213
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.